The OD's Role in Reducing Dementia Risk and Maintaining Independence in Older Adults - Summary - MDSpire

The OD's Role in Reducing Dementia Risk and Maintaining Independence in Older Adults

Presenters discussed the optometrist’s role in reducing dementia risk and maintaining independence in older adults.

  • October 1, 2025

  • 2 min

Share

Objective:

To discuss the optometrist's role in reducing dementia risk and maintaining independence in older adults through vision care.

Key Findings:
  • Vision issues are linked to an increased risk of cognitive impairment.
  • Preventable conditions like cataracts and glaucoma are commonly managed by optometrists.
  • Medications can influence both ocular and cognitive health.
Interpretation:

Treating vision problems in older adults can help prevent or slow cognitive decline, thereby enhancing overall health and independence.

Limitations:
  • The presentation did not provide specific intervention strategies for optometrists.
  • Further research is needed to establish direct causal relationships between vision care and cognitive health.
Conclusion:

Optometrists play a crucial role in maintaining cognitive health in older adults by addressing vision issues, which can lead to improved patient outcomes.

Original Source(s)

The OD's Role in Reducing Dementia Risk and Maintaining Independence in Older Adults

  • October 1, 2025

Related Content

The Myopia Control Kit

Thomas Aller, OD, provides in-depth overviews of each myopia management option—pharmacologic therapy, soft contact lenses, orthokeratology, spectacle lenses, and environmental and behavioral interventions—so clinicians can not only provide the right option to each patient, but also address the larger economic and societal burdens of myopia.

Advanced bilateral glaucoma decades after first-generation Fyodorov ‘collar-button’ anterior–posterior phakic intraocular lens implantation: a case report and clinical management considerations

Hydrus®: The Long-Term Evidence

Professor Gus Gazzard* outlines the five-year results of the HORIZON study, evaluating the safety and efficacy of the Hydrus® Microstent

  • April 24, 2026

  • 5 min